TrialHeadache2025

Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial.

Anna Gryglas-Dworak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.